“a favorable trend”

Although anti-EGFR therapy in the first-line setting has a favorable trend compared with anti-VEGF therapy, the treatment strategy in RAS wild type mCRC has been controversial.

CMT showed a favorable trend towards the NSAIDs group with a mean difference of 51.84 μm (95% CI: -15.23 to 118.91), although this was not statistically significant, with high heterogeneity (I^2 = 91%, P < 0.0001).

Thus, the Perioperative chemotherapy versus surveillance in upper Tract urothelial cancer (POUT) trial revealed a significant improvement in DFS, MFS, and DSS with a favorable trend in OS for adjuvant chemotherapy in locally advanced UTUC.

In the present study, the average age of the patients was higher and the average visual acuity was better, indicating a favorable trend in pericentral RP compared to typical RP.

The physical and vitality scores of the 36-item short-form (SF-36) showed a favorable trend in the exercise group compared with the control group.

A recent study among UK participants [29] demonstrated a favorable trend in publicly provided psychotherapy and SES indicating that the treatment needs of those with the highest risk were better met in the public sector than previously.

A favorable trend has been witnessed during the last 40 years, with a remarkable progress in the assembly and conservation of plant genetic resources [ 1 – 3 ].

5 Conclusions This prospective clinical case series suggests that the adjunctive use of advanced platelet‐rich fibrin (A‐PRF) in the surgical management of MRONJ is associated with a favorable trend toward mucosal healing; however, in the absence of a control group, definitive conclusions regarding its efficacy cannot be drawn.

While there was no statistically significant difference in freedom from any atrial arrhythmia after a single procedure in the overall per-protocol population (HR, 0.81; 95% CI, 0.56–1.19), a favorable trend emerged after one or two procedures (HR, 0.62; 95% CI, 0.38–1.01) [ 17 ].

Post-treatment analgesic use showed a favorable trend in the BioSi-DK group: 68.4% discontinued analgesics entirely (no analgesic use post-treatment) compared with 36.8% of controls.

The analysis showed a difference in treatment effect between participants with and without previous MI, with a favorable trend for the effect in TM vs.

The administration of anamorelin as a second-line or earlier treatment resulted in significant appetite improvement and BW gain at 3 weeks, with a favorable trend also observed in appetite improvement and BW gain at 12 weeks.

The results revealed that compared to docetaxel, enzalutamide sequential therapy (HR: 0.22, 95% CI: 0.03–1.67) and enzalutamide combined therapy (HR: 0.46, 95% CI: 0.06–3.07) exhibited a favorable trend in enhancing the time to PSA progression in mHSPC patients ( Supplementary Material 6R ).

Network Meta-Analysis In terms of overall survival, the forest plot illustrates that IC + RT&MTT (HR .68, 95% CrI 0.25-1.8), IC + CRT&MTT (HR .72, 95% CrI 0.071-7.4), and MTT-CRT (HR .93, 95% CrI 0.80-1.1) show a favorable trend over CRT.

While some studies have reported an increased rate of infection in older patients, others have observed a favorable trend with increasing age.

Notably, the pregnancy outcomes showed a favorable trend in the early hysteroscopy group, but there were no statistically significant differences.

The addition of pembrolizumab was associated with a favorable trend toward improved event-free survival versus placebo plus CRT, but the difference did not reach statistical significance in the ITT population (the 24-month event-free survival rate was 63.2% for the pembrolizumab arm versus 56.2% in the placebo arm). 62 Currently, several clinical trials are exploring the role of different ICIs in LACC setting ( Table 1 ).

Comparison of matched samples from BASE-II and BASE demonstrated a favorable trend for HbA1c.

Regarding economic outcomes, while not statistically significant, a favorable trend was observed in the early-testing group, with a shorter median length of hospital stay (8.0 vs. 9.0 days) and lower median total hospitalization costs (8,392 vs. 9,696 CNY).

There was also significantly less worsening in the hematology BILAG domain and a favorable trend in the vasculitis and renal domains. 29 Significant improvements were seen in both belimumab groups of BLISS-52 in the SFI flare rate and time to first flare, although the severe SFI flare rate and the rate of new BILAG 1A/2B scores at 52 weeks were significantly reduced only in the 10 mg/kg belimu

22 , 23 A previous study has demonstrated a favorable trend in reducing TC and non-HDL-C from 1999 to 2011 in Tehran; however, it was limited due to the small sample size and single-district sampling. 24 Since then, no other study has evaluated the prevalence of dyslipidemia in Tehran, and its current net prevalence remains unknown.

[ 7 ] reported that treatment with TTR stabilizers in asymptomatic patients with ATTR-CM was associated with improved long-term survival, with a favorable trend toward reducing or delaying the development of clinical HF.

This may reflect a favorable trend in early neuromotor development.

Previous studies have shown that the sensitivity of EUS-TA for ML was 80% and 60.5% with FNB and FNA, respectively, indicating a favorable trend for FNB. 26 In our study, the sensitivity for cytology was 75% and 50% with FNB and FNA, respectively, while that for histological diagnosis was 100% and 78.9% with FNB and FNA, respectively.

Concerning APACHE II scores, our results suggest a favorable trend in mortality reduction with prolonged infusion in critically ill patients, irrespective of an APACHE II score above or below 20, differing from Roberts’ meta-analysis findings [ 38 ].